Mamu-B*08-positive macaques control simian immunodeficiency virus replication
about
MHC class I characterization of Indonesian cynomolgus macaquesMHC and KIR Polymorphisms in Rhesus Macaque SIV InfectionNonhuman primate models for HIV/AIDS vaccine developmentSIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humansNatural SIV hosts: showing AIDS the doorVaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replicationEarly Loss of Splenic Tfh Cells in SIV-Infected Rhesus MacaquesImmunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaquesEx vivo SIV-specific CD8 T cell responses in heterozygous animals are primarily directed against peptides presented by a single MHC haplotypeGagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivoKinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infectionsA highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS modelStructural Illumination of Equine MHC Class I Molecules Highlights Unconventional Epitope Presentation Manner That Is Evolved in Equine Leukocyte Antigen AllelesThe population genomics of rhesus macaques (Macaca mulatta) based on whole-genome sequencesLong-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccineGenomic plasticity of the MHC class I A region in rhesus macaques: extensive haplotype diversity at the population level as revealed by microsatellitesHIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesisVaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus MacaquesRecent Insights into the HIV/AIDS Pandemic.Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles.Why primate models matter.Control of SIV infection and subsequent induction of pandemic H1N1 immunity in rhesus macaques using an Ad5 [E1-, E2b-] vector platform.Animal models for HIV/AIDS researchCD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisCD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaquesImmunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titersTwo MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity.Effective simian immunodeficiency virus-specific CD8+ T cells lack an easily detectable, shared characteristic.Major histocompatibility complex genotyping with massively parallel pyrosequencingEfficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challengeTRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new speciesComplete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization.Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge.Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.
P2860
Q24655548-F4FF421C-AAC3-4CD6-AE4D-AEFC85CEB5ACQ26777946-D0EF7AB3-4F9D-47A1-A348-1551AD53AD70Q26861148-FC4048DE-C15A-49EE-9505-B7A24B20378BQ27014903-86AFD65E-08AA-4B0C-A3EE-2515B8EFC0D0Q27026135-252381BE-9D6D-456D-8D38-266DDFB89339Q27315009-B69C344B-EB33-449F-894B-0EFE9E504023Q27316803-79581FB2-8EA8-4500-97FD-7A74DDBD22FCQ27319783-D1A37966-E2E5-4F85-B5C3-0DE17E47F3DEQ27322650-62D98810-FC72-48DD-83D3-8D46DEEEBF1BQ27324128-6243E33B-13A7-448F-8F4F-F2AF1B2ECA71Q27333255-F162305C-7D21-4CE3-BC4B-F98602A77FBAQ27344720-400589A6-1B12-4E32-BE43-2742D695EB76Q27703610-DF593785-3BCD-46EB-8675-1D67191AAACAQ28591103-258861F0-889C-4403-8AB0-EFCE1C8228A2Q28743435-C3A2251D-FE98-44F4-AD20-C0E5D94F5FE3Q28743577-E5A87609-EAF8-44A0-9CAE-6ACA52C0586EQ28751706-63E350A2-2094-4AA5-9C89-C0735F41FD87Q28830298-449B6BD0-6794-41E1-BDAA-78370DD18545Q30235024-2DFA2A2C-07E3-4201-B72A-3C1EFE1B168EQ30413358-342B37C2-EB53-4B9E-90FD-969FA075251FQ30417520-67494804-E38F-4511-A319-C83632D4A399Q30422006-E1007C13-375F-482B-A3C3-B1FB658009EAQ30423656-3CBD027F-06C1-4D6B-8BD3-D35534EE31B5Q30432007-59276421-15F9-44F0-AA71-06C0044EA248Q33305428-B83F1B18-A0CF-4C62-B60F-10C6DFA3DD04Q33342850-923A9D88-5C75-48F0-930B-28462162239AQ33402455-EDA0AC17-41A0-49CB-B145-BBB807FB9E1EQ33444658-E69860AC-5CB9-490C-A30E-79B4BF4F3004Q33459720-5DE8C729-AB96-4163-A1C8-BEC87F36AB10Q33558348-6B94C760-8E92-409A-B260-3C7DFF9FC22DQ33666735-F390F4E8-708D-49CA-BADE-831912884F59Q33676444-98530EBC-E455-4E95-8279-A20378E6B7D0Q33680119-E5845359-391C-4B90-BF57-0A6A4BC3BBE3Q33704001-AB9FF80C-A23C-426E-89AF-4D405F9F10A0Q33744109-D7C4C422-5887-44A1-95C4-17E7AE2E7476Q33826671-54DCB1BD-B60F-4EA4-8250-B6DA660E34E9Q33839468-6DBBCA90-74A3-4162-8C3E-E8D3559804A5Q33856394-166B3870-C461-47DB-80C6-48AC74F2AF85Q33879572-634DC4E0-C8FB-4F76-ADE9-72027F6E63A9Q33888012-D5299942-9FC4-4E1D-836B-2C252089990D
P2860
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@ast
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@en
type
label
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@ast
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@en
prefLabel
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@ast
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@en
P2093
P2860
P356
P1433
P1476
Mamu-B*08-positive macaques control simian immunodeficiency virus replication
@en
P2093
Alex T Bean
Chrystal E Glidden
Dominic R Beal
Gretta J Borchardt
Jeffrey D Lifson
Jess Maxwell
John T Loffredo
Nancy A Wilson
Taeko Soma
William M Rehrauer
P2860
P304
P356
10.1128/JVI.00895-07
P407
P577
2007-05-30T00:00:00Z